SIM-0503

N/A

Report date: 2023/06/09 13:33:24

Base Information

Drug NameSIM-0503
Drug Alias NameSIM-0503
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesHainan Xiansheng Re Ming Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHainan Xiansheng Re Ming Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A